DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 151 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $154,732 | -86.5% | 10,015 | -70.2% | 0.00% | -75.0% |
| Q3 2021 | $1,143,000 | -28.7% | 33,639 | -23.2% | 0.00% | -33.3% |
| Q2 2021 | $1,603,000 | -59.8% | 43,794 | -50.7% | 0.01% | -66.7% |
| Q1 2021 | $3,985,000 | -48.9% | 88,866 | -35.0% | 0.02% | -47.1% |
| Q4 2020 | $7,806,000 | -0.4% | 136,776 | -10.5% | 0.03% | +9.7% |
| Q3 2020 | $7,840,000 | +0.2% | 152,837 | +16.6% | 0.03% | -20.5% |
| Q2 2020 | $7,827,000 | +315.2% | 131,075 | +186.3% | 0.04% | +225.0% |
| Q1 2020 | $1,885,000 | -43.3% | 45,786 | -14.3% | 0.01% | +9.1% |
| Q4 2019 | $3,326,000 | +208.2% | 53,433 | +68.0% | 0.01% | +175.0% |
| Q3 2019 | $1,079,000 | +838.3% | 31,800 | +983.8% | 0.00% | – |
| Q2 2018 | $115,000 | – | 2,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
| SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
| Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
| Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
| Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
| Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
| Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
| SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
| Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
| Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |